References
- Auld, D. S., Veith, H. and Cali, J. J. (2013) Bioluminescent assays for cytochrome CYP enzymes. Methods Mol. Biol. 987, 1-9. https://doi.org/10.1007/978-1-62703-321-3_1
- Bosetti, A., Sobol, M., Ma, D., Good T., Liu, D. and Cali, J. J. (2005) Bioluminescent cytochrome CYP assays. Pharmacologyonline 3, 9-18.
- Cali, J. J., Ma, D., Sobol, M., Simpson, D. J., Frackman, S., Good, T. D., Daily, W. J. and Liu, D. (2006) Luminogenic cytochrome CYP assays. Expert Opin. Drug Metab. Toxicol. 2, 629-645. https://doi.org/10.1517/17425255.2.4.629
- Cali, J. J., Niles, A., Valley, M. P., O'Brien, M. A., Riss, T. L. and Shultz, J. (2008) Bioluminescent assays for ADMET. Expert Opin. Drug Metab. Toxicol. 4, 103-120. https://doi.org/10.1517/17425255.4.1.103
- Garcia, M. C., Ma, D., Dicioccio, A. T. and Cali, J. (2008) The use of a high-throughput luminescent method to assess CYP3A enzyme induction in cultured rat hepatocytes. In Vitro Cell. Dev. Biol. Anim. 44, 129-134. https://doi.org/10.1007/s11626-008-9085-1
- Kim, S. H., Park, Y. S., Kim, J. M., Park, H. J., Lee, M. H., Park, H. K., Kim, Y. J., Cho, S. H., Shaw, L. M. and Kang, J. S. (2012) Pharmacokinetic and bioavailability studies of 5 mg mosapride tablets in healthy Korean volunteers. Int. J. Clin. Pharmacol. Ther. 50, 524-531.
- Mann, H. J. (2006) Drug-associated disease: cytochrome CYP interactions. Crit. Care Clin. 22, 329-345, vii. https://doi.org/10.1016/j.ccc.2006.02.004
- Ofotokun, I. (2005) Sex differences in the pharmacologic effects of antiretroviral drugs: potential roles of drug transporters and phase 1 and 2 metabolizing enzymes. Top. HIV Med. 13, 79-83.
- Ogu, C. C. and Maxa, J. L. (2000) Drug interactions due to cytochrome CYP. Proc. (Bayl. Univ. Med. Cent.) 13, 421-423.
- Parkinson, A., Mudra, D. R., Johnson, C., Dwyer, A. and Carroll, K. M. (2004). The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome CYP enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol. Appl. Pharmacol. 199, 193-209. https://doi.org/10.1016/j.taap.2004.01.010
- Wiersma, H., Escher, J. C., Dilger, K., Trenk, D., Benninga, M. A., van Boxtel, C. J. and Taminiau, J. (2004) Pharmacokinetics of mesalazine pellets in children with inflammatory bowel disease. Inflamm. Bowel Dis. 10, 626-631. https://doi.org/10.1097/00054725-200409000-00019
- Wrighton, S. A. and Stevens, J. C. (1992) The human hepatic cytochromes CYP involved in drug metabolism. Crit. Rev. Toxicol. 22, 1-21. https://doi.org/10.3109/10408449209145319
- Zanger, U. M. and Schwab, M. (2013) Cytochrome CYP enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol. Ther. 138, 103-141. https://doi.org/10.1016/j.pharmthera.2012.12.007
Cited by
- Smoking and antidepressants pharmacokinetics: a systematic review vol.16, pp.1, 2017, https://doi.org/10.1186/s12991-017-0140-8
- Pharmacokinetics of YJC-10592, a novel chemokine receptor 2 (CCR-2) antagonist, in rats vol.39, pp.6, 2016, https://doi.org/10.1007/s12272-016-0748-2
- Inhibition of the RhoGTPase Cdc42 by ML141 enhances hepatocyte differentiation from human adipose-derived mesenchymal stem cells via the Wnt5a/PI3K/miR-122 pathway: impact of the age of the donor vol.9, pp.1, 2018, https://doi.org/10.1186/s13287-018-0910-5
- Current High-Throughput Approaches of Screening Modulatory Effects of Xenobiotics on Cytochrome P450 (CYP) Enzymes vol.7, pp.4, 2015, https://doi.org/10.3390/ht7040029
- Role of cytochrome P450 polymorphisms and functions in development of ulcerative colitis vol.25, pp.23, 2019, https://doi.org/10.3748/wjg.v25.i23.2846
- Influence of gastrointestinal activity on the absorption of nilotinib vol.35, pp.1, 2015, https://doi.org/10.1016/j.dmpk.2019.08.006
- The tissue distribution and excretion study of mosapride and its active des-p-fluorobenzyl and 4′-N-oxide metabolites in rats by ultra-high performance liquid chromatography-tandem mass spectrom vol.50, pp.2, 2015, https://doi.org/10.1080/00498254.2019.1588410
- International Normalized Ratio (INR) Increases amongst Two Patients Living with HIV on Warfarin after Being Switched from a Nevirapine to a Dolutegravir-Based Antiretroviral Regimen vol.2021, pp.None, 2015, https://doi.org/10.1155/2021/9384663